Literature DB >> 12709810

Tumefactive fibroinflammatory lesion of the head and neck treated with steroids: a case report.

F Hostalet1, D Hellin, J A Ruiz.   

Abstract

Tumefactive fibroinflammatory lesion is an idiopathic fibrosclerosing disorder of the head and neck region that clinically simulates a malignant process, but is histologically benign. This lesion is believed to be part of a broader fibrosclerotic syndrome that includes idiopathic mediastinal and retroperitoneal fibrosis, sclerosing cholangitis and Riedel's thyroiditis. The tumefactive fibroinflammatory lesion differs from other fibrosing conditions encountered in the head and neck region: fibromatoses, nodular fasciitis and fibrosarcomas. Although there is no optimum treatment, steroid therapy is suggested as the first line of management. Our patient was treated with corticosteroids and had a favourable response, supporting this approach as the initial treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12709810     DOI: 10.1007/s00405-002-0531-5

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  4 in total

1.  Tumefactive fibroinflammatory lesion: a rare aetiology for a neck mass in an old Iranian man.

Authors:  F Binesh; S H Taghipour; H Navabii
Journal:  BMJ Case Rep       Date:  2011-06-21

2.  Progressive tumefactive fibroinflammatory lesion of the infratemporal fossa treated by radiation therapy.

Authors:  Frank J P Hoebers; Bayardo Perez Ordonez; Jon Irish; Rand E Simpson; Eugene Yu; Brian O'Sullivan
Journal:  Rare Tumors       Date:  2012-03-09

3.  Riedel's thyroiditis: impact and strategy of a challenging surgery.

Authors:  Kerstin Lorenz; Oliver Gimm; Hans Jürgen Holzhausen; Stephan Kittel; Jörg Ukkat; Phuong Nguyen Thanh; Michael Brauckhoff; Henning Dralle
Journal:  Langenbecks Arch Surg       Date:  2007-04-03       Impact factor: 2.895

4.  Tumefactive Fibroinflammatory Lesion: A Diagnostic Dilemma.

Authors:  Promil Jain; Rajeev Sen; Nisha Sharma; Shilpi Bhargava; Virender Singh
Journal:  Iran J Med Sci       Date:  2017-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.